Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 686,182 | 685,182 | -1,000 | $35.50M | $38.75M | 31.53% | +$3.25M |
| Biodesix, Inc.(BDSX) | 5,696,113 | 5,736,113 | +40,000 | $10.12M | $8.78M | 7.14% | -$1.35M |
| Acadia Pharmaceuticals Inc | 400,400 | 338,400 | -62,000 | $6.16M | $6.21M | 5.05% | +$51.5K |
| Elutia Inc.(ELUT) | 1,321,215 | 1,225,489 | -95,726 | $5.03M | $4.58M | 3.73% | -$450.5K |
| Prothena Corp PlcSHS SHS | 209,574 | 304,574 | +95,000 | $3.51M | $4.22M | 3.43% | +$712.2K |
| Neurocrine Biosciences, Inc.(NBIX) | 30,240 | 30,240 | 0 | $3.48M | $4.13M | 3.36% | +$643.5K |
| Corcept Therapeutics Incorporated(CORT) | 74,000 | 74,000 | 0 | $3.42M | $3.73M | 3.03% | +$304.1K |
| United Therapeutics Corporation(UTHR) | 10,000 | 10,000 | 0 | $3.58M | $3.53M | 2.87% | -$55.1K |
| Axogen, Inc.(AXGN) | 197,000 | 197,000 | 0 | $2.76M | $3.25M | 2.64% | +$484.6K |
| DocGo Inc.(DCGO) | 515,000 | 764,062 | +249,062 | $1.71M | $3.24M | 2.64% | +$1.53M |
| Quidelortho Corp | 67,619 | 67,619 | 0 | $3.08M | $3.01M | 2.45% | -$71.0K |
| Phreesia, Inc.(PHR) | 114,700 | 114,700 | 0 | $2.61M | $2.89M | 2.35% | +$271.8K |
| Travere Therapeutics, Inc.(TVTX) | 148,000 | 148,000 | 0 | $2.07M | $2.58M | 2.10% | +$507.6K |
| Masimo Corp | 15,280 | 15,280 | 0 | $2.04M | $2.53M | 2.06% | +$488.5K |
| Harrow, Inc.(HROW) | 72,910 | 72,910 | 0 | $3.28M | $2.45M | 1.99% | -$831.9K |
| Stoke Therapeutics, Inc.(STOK) | 210,000 | 210,000 | 0 | $2.58M | $2.32M | 1.88% | -$264.6K |
| Ovintiv Inc.(OVV) | 52,200 | 52,200 | 0 | $2.00M | $2.11M | 1.72% | +$114.3K |
| Castle Biosciences, Inc.(CSTL) | 58,000 | 78,000 | +20,000 | $1.65M | $2.08M | 1.69% | +$424.5K |
| Protagonist Therapeutics Inc | 48,000 | 48,000 | 0 | $2.16M | $1.85M | 1.51% | -$307.2K |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $1.27M | $1.60M | 1.30% | +$327.8K |
| Foghorn Therapeutics Inc.(FHTX) | 320,930 | 310,930 | -10,000 | $2.99M | $1.47M | 1.19% | -$1.52M |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.40M | $1.44M | 1.17% | +$38.5K |
| Treace Medical Concepts, Inc.(TMCI) | 68,350 | 161,350 | +93,000 | $396.4K | $1.20M | 0.98% | +$804.0K |
| NovoCure Limited(NVCR) | 20,000 | 31,000 | +11,000 | $312.6K | $923.8K | 0.75% | +$611.2K |
| 10x Genomics, Inc.CL A(TXG) | 30,000 | 50,000 | +20,000 | $677.4K | $718.0K | 0.58% | +$40.6K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 16,000 | +16,000 | $0 | $673.1K | 0.55% | +$673.1K |
| Xencor, Inc.(XNCR) | 12,300 | 26,000 | +13,700 | $247.4K | $597.5K | 0.49% | +$350.1K |
| Kiniksa Pharmaceuticals Ltd | 30,000 | 30,000 | 0 | $749.7K | $593.4K | 0.48% | -$156.3K |
| Kalvista Pharmaceuticals Inc | 82,000 | 67,000 | -15,000 | $949.6K | $567.5K | 0.46% | -$382.1K |
| Alphatec Holdings, Inc.(ATEC) | 198,000 | 58,000 | -140,000 | $1.10M | $532.4K | 0.43% | -$568.4K |
| Candel Therapeutics, Inc.(CADL) | 0 | 60,000 | +60,000 | $0 | $520.8K | 0.42% | +$520.8K |
| Wave Life Sciences, Inc.SHS(WVE) | 40,000 | 40,000 | 0 | $328.0K | $494.8K | 0.40% | +$166.8K |
| Inhibrx Biosciences, Inc.(INBX) | 32,110 | 32,110 | 0 | $502.8K | $494.5K | 0.40% | -$8.3K |
| Halozyme Therapeutics, Inc.(HALO) | 10,000 | 10,000 | 0 | $572.4K | $478.1K | 0.39% | -$94.3K |
| Cytokinetics, Incorporated(CYTK) | 10,000 | 10,000 | 0 | $528.0K | $470.4K | 0.38% | -$57.6K |
| Apellis Pharmaceuticals Inc COM | 14,000 | 14,000 | 0 | $403.8K | $446.7K | 0.36% | +$43.0K |
| Sarepta Therapeutics, Inc.(SRPT) | 2,500 | 3,500 | +1,000 | $312.2K | $425.6K | 0.35% | +$113.3K |
| Outset Medical, Inc.(OM) | 10,000 | 368,766 | +358,766 | $6.8K | $409.3K | 0.33% | +$402.6K |
| Xenon Pharmaceuticals Inc.(XENE) | 10,000 | 10,000 | 0 | $393.7K | $392.0K | 0.32% | -$1.7K |
| Accelerate Diagnostics Inc | 325,239 | 325,239 | 0 | $556.2K | $390.3K | 0.32% | -$165.9K |
| TELA Bio, Inc.(TELA) | 0 | 125,000 | +125,000 | $0 | $377.5K | 0.31% | +$377.5K |
| Springworks Therapeutics Inc | 10,000 | 10,000 | 0 | $320.4K | $361.3K | 0.29% | +$40.9K |
| uniQure N.V.SHS(QURE) | 20,000 | 20,000 | 0 | $98.6K | $353.2K | 0.29% | +$254.6K |
| Pulmonx Corporation(LUNG) | 0 | 51,000 | +51,000 | $0 | $346.3K | 0.28% | +$346.3K |
| Scholar Rock Holding Corporation(SRRK) | 0 | 8,000 | +8,000 | $0 | $345.8K | 0.28% | +$345.8K |
| Axsome Therapeutics, Inc.(AXSM) | 4,000 | 4,000 | 0 | $359.5K | $338.4K | 0.28% | -$21.0K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 40,000 | 40,000 | 0 | $304.0K | $300.8K | 0.24% | -$3.2K |
| Atara Biotherapeutics Inc | 0 | 22,000 | +22,000 | $0 | $292.8K | 0.24% | +$292.8K |
| Arvinas, Inc.(ARVN) | 15,000 | 15,000 | 0 | $369.4K | $287.6K | 0.23% | -$81.9K |
| Karyopharm Therapeutics Inc.(KPTI) | 469,832 | 419,832 | -50,000 | $390.0K | $283.9K | 0.23% | -$106.0K |
| Biohaven Pharmaceutical Holding Co Ltd | 7,365 | 7,365 | 0 | $368.0K | $275.1K | 0.22% | -$92.9K |
| Amicus Therapeutics Inc COM | 28,000 | 28,000 | 0 | $299.0K | $263.8K | 0.21% | -$35.3K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $334.8K | $243.6K | 0.20% | -$91.2K |
| Keros Therapeutics, Inc.(KROS) | 7,000 | 15,000 | +8,000 | $406.5K | $237.4K | 0.19% | -$169.0K |
| Blueprint Medicines Corp | 2,700 | 2,700 | 0 | $249.8K | $235.5K | 0.19% | -$14.3K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 4,000 | +4,000 | $0 | $216.6K | 0.18% | +$216.6K |
| Zenas BioPharma, Inc.(ZBIO) | 0 | 16,500 | +16,500 | $0 | $135.1K | 0.11% | +$135.1K |
| Direxion Daily Pharmaceutical & Medical Bull 3x ShDLY TECH BULL 3X DA TE BU 3X ETF | 0 | 18,000 | +18,000 | $0 | $127.8K | 0.10% | +$127.8K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 138,176 | 0 | $136.3K | $125.0K | 0.10% | -$11.3K |
| InflaRx N.V.(IFRX) | 50,000 | 50,000 | 0 | $76.5K | $123.5K | 0.10% | +$47.0K |
| Liquidia Corporation(LQDA) | 10,000 | 10,000 | 0 | $100.0K | $117.6K | 0.10% | +$17.6K |
| Coherus Oncology, Inc.(CHRS) | 372,000 | 82,000 | -290,000 | $386.9K | $113.2K | 0.09% | -$273.7K |
| NeuroPace, Inc.(NPCE) | 0 | 10,000 | +10,000 | $0 | $111.9K | 0.09% | +$111.9K |
| Alumis Inc | 10,000 | 10,000 | 0 | $106.8K | $78.6K | 0.06% | -$28.2K |
| Ventyx Biosciences Inc | 28,800 | 28,800 | 0 | $62.8K | $63.1K | 0.05% | +$288 |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 16,000 | 17,000 | +1,000 | $58.9K | $51.5K | 0.04% | -$7.4K |
| 2seventy Bio Inc | 15,833 | 15,833 | 0 | $74.7K | $46.5K | 0.04% | -$28.2K |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 12,972 | 12,972 | 0 | $1.2K | $778 | 0.00% | -$432 |
| Bluebird Bio Inc | 211,200 | 0 | -211,200 | $109.7K | $0 | — | -$109.7K |
| Cabaletta Bio, Inc.(CABA) | 10,000 | 0 | -10,000 | $47.2K | $0 | — | -$47.2K |
| Progyny Inc | 22,000 | 0 | -22,000 | $368.7K | $0 | — | -$368.7K |